Eyal Lifschitz - Profile and Investment Details

Investor Profile

Eyal Lifschitz is a Incubator, Micro VC, Venture Capital, Private Equity Firm, Growth Operator, Entrepreneurship Program based in Israel with a diverse investment portfolio that includes companies such as Restore Medical Solutions, ArTack Medical, BioRefine, Heracure Medical, MarketYze, Jobrain, Raziel Therapeutics, Roby.AI, Otic Pharma, Valtech Cardio, CartiHeal, Cellvine, CardioNova, Evolero, Rise.ai, Restore Medical, Blue White Robotics, Topspin Medical, Peak-Dynamics, SinuSafe Medical, Zuznow, Magneto Thrombectomy, Digma Medical, NeuroApplied, Memic Innovative Surgery, ShapeDo, Eximo Medical, Kailight Photonics, NLT SPINE, Artfix, CORDIO Medical, WhiteSource, mPharma, Rocketick, OutSense, BioProtect, Valire, Eve Pharma, Aleph Farms, Yotta Green, NitiNotes, Levation Pharma, CliClap, CardioGard Medical, VisionCare Ophthalmic Technologies, Payzday, Hairstetics, Endomatic, Kymera Labs, Quicklizard, Neovasc. Over time, Eyal Lifschitz has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Eyal Lifschitz is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Autonomous Vehicles, Wellness, Medical Testing, Medical Software, Automotive, Robotics, Startups, Food Tech, Marketplace, Social Entrepreneurship, Medical Device, Software, Manufacturing, Healthcare, Biotechnology, AgTech, Cars autonomous vehicles, Agriculture, Early Stage IT, Health Diagnostics, Digital Health, Drones, Medical, Health Tech, Media and Entertainment, Pharmaceuticals, Diversity-focused Venture Capital may find it worthwhile to explore potential connections with Eyal Lifschitz, as their portfolio suggests a familiarity and interest in this area.

Understanding Eyal Lifschitz’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.